metricas
covid
Buscar en
Actas Urológicas Españolas
Toda la web
Inicio Actas Urológicas Españolas Expresión de Citoqueratina 5 y Calretinina en el carcinoma renal de células cl...
Journal Information
Vol. 30. Issue 4.
Pages 367-371 (January 2006)
Share
Share
Download PDF
More article options
Vol. 30. Issue 4.
Pages 367-371 (January 2006)
Expresión de Citoqueratina 5 y Calretinina en el carcinoma renal de células claras
Expression of cytokeratin 5 and calretinin in clear cell renal cell carcinoma
Visits
1380
P. Cid Mouteiraa, J.A. Ortiz-Reya,1
Corresponding author
jaortiz@povisa.es

Dr. J.A. Ortiz Rey. Anatomía Patológica. POVISA. Salamanca, 5 - 36211 Vigo (Pontevedra)
, C. Gómez de Maríaa, P. San Miguel Frailea, A. Albor Barrosoa, B. Regueiro Parceroa, I. Antón Badiolaa
a Servicio de Anatomía Patológica. Hospital Povisa. Vigo (Pontevedra)
This item has received
Article information
Resumen
Objetivo

La citoqueratina 5 (CK5) y la calretinina se han revelado en numerosos estudios como marcadores inmunohistoquímicos sugestivos de mesotelioma y su análisis se utiliza para el diagnóstico diferencial histológico con adenocarcinomas, especialmente ante metástasis de origen desconocido. En el presente estudio hemos analizado la expresión de CK5 y calretinina en el carcinoma renal de células claras

Métodos

Se estudió un total de 63 casos de carcinoma renal de células claras. De ellos, 46 fueron incluidos en dos matrices tisulares (“tissue arrays”), y un segundo grupo, de 17 casos, estuvo constituido por bloques convencionales de tumores de alto grado (grado 4 de Fuhrman)

Se realizaron tinciones inmunohistoquímicas con anticuerpos monoclonales anti CK5 y anti calretinina, mediante el método de estreptavidina marcada con peroxidasa-biotina

Resultados

No se obtuvo positividad en ninguno de los casos para calretinina, mientras que la CK5 se expresó focalmente, en células aisladas, en 1 de los 63 casos (1,59%), que correspondió a un carcinoma de alto grado (grado 4 de Fuhrman)

Conclusiones

En el carcinoma renal de células claras no hemos observado expresión de calretinina y la positividad para CK5 ha ocurrido de manera aislada y en un porcentaje muy pequeño de células tumorales. Por tanto, en la práctica si bien la positividad para estos marcadores no excluye de manera absoluta carcinoma de células renales, dicho resultado es muy improbable en este tumor y obliga a considerar otras opciones diagnósticas

Palabras Clave:
Carcinoma renal
Carcinoma de células claras
Citoqueratina 5
Calretinina
Inmunohistoquímica
Abstract
Purpose

Cytokeratin 5 (CK5) and calretinin have been useful in different studies as immunohistochemical markers suggestive of mesothelioma, and their expression is analyzed for the histological differential diagnosis with adenocarcinomas, specially when confronting with metastatic tumors of unknown origin. We have analyzed the expression of CK5 and calretinin in clear cell renal cell carcinoma

Methods

A series of 63 clear cell renal cell carcinomas was studied. 46 of these cases were embedded in two tissue arrays, and a second group, of 17 cases, was constituted by conventional paraffin blocks from high-grade tumors (grade 4 of Fuhrman)

Immunohistochemical staining was performed with monoclonal antibodies against CK5 and calretinin, following the labeled sptreptavidin-biotin technique

Results

No positivity for calretinin was observed in any case, while CK5 was focally expressed, in an isolated group of cells, in 1 of the 63 cases (1,59%) which corresponded to a high-grade carcinoma (grade 4 of Fuhrman)

Conclusions

Expression of calretinin was not observed in clear cell renal cell carcinoma and positivity for CK5 occurred only in one case, in a very small proportion of tumor cells. Therefore, in practice, although the positivity for these markers cannot completely exclude renal cell carcinoma, this result is very rare in this tumor and other diagnostic posibilities should be considered

Key Words:
Renal carcinoma
Clear cell carcinoma
Cytokeratin 5
Calretinin
Immunohistochemistry

Article

These are the options to access the full texts of the publication Actas Urológicas Españolas
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Actas Urológicas Españolas

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos